Bristol Myers Squibb and Johnson & Johnson Pause a Study on New Blood Thinner Drug
Two big drug companies, Bristol Myers Squibb and Johnson & Johnson, have stopped a major study on a new experimental […]
Big Pharma MSD Buys Cidara for $9.2bn to Boost Infectious Disease Drugs
MSD, a large pharmaceutical company, has agreed to buy Cidara Therapeutics for $9.2 billion. This deal will add a new
Evotec and Bristol Myers Squibb Reach Important Milestone in Drug Development
Evotec, a biopharmaceutical company based in Hamburg, Germany, has received a $5 million payment from Bristol Myers Squibb. This payment
Mangoceuticals’ Stock Drops After Drugmakers Deny Partnership
Mangoceuticals, a company that sells medicines online, said it had teamed up with drugmakers Eli Lilly and Novo Nordisk to
FDA Approves Johnson & Johnson’s Darzalex Faspro for Early-Stage Multiple Myeloma
Johnson & Johnson’s cancer drug, Darzalex Faspro, has been approved by the FDA for use in a very early stage
Pharmaceutical News
New Method for Making Medicines Could Be a Game Changer
Researchers have found a simple way to start chemical reactions that could help make small molecule drugs. This could be
Johnson & Johnson’s New Drug Approved for Severe Depression
Johnson & Johnson has received approval from the Food and Drug Administration (FDA) to sell its drug Caplyta for treating
New Hope for Multiple Myeloma Patients: HDP-101 Shows Promising Results
Heidelberg Pharma has shared good news about their HDP-101 treatment for multiple myeloma, a type of blood cancer. This treatment
CNX Therapeutics Takes Over Sativex to Boost Nervous System Treatment Options
CNX Therapeutics has taken over the global rights to Sativex (nabiximols) from Jazz Pharmaceuticals. This deal, finalized on October 31,
Pharmaceutical News
Heating Chemicals Could Make Drug Production Easier and Cheaper
A new, budget-friendly method that uses heat to start important chemical reactions could make large-scale drug production faster and more